Cargando…

1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats

BACKGROUND: Antimicrobial resistance (AR) poses a major global threat, with a reported 1.27 million deaths in 2019. This resulted in years of life lost as well as a large burden on the healthcare system. Transmission of resistant pathogens is not limited to one geographic area and can easily be infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit, Tina, Aubert, Rachael, Clemente, Jacob, Sievert, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677199/
http://dx.doi.org/10.1093/ofid/ofad500.1212
_version_ 1785150073660768256
author Benoit, Tina
Aubert, Rachael
Clemente, Jacob
Sievert, Dawn
author_facet Benoit, Tina
Aubert, Rachael
Clemente, Jacob
Sievert, Dawn
author_sort Benoit, Tina
collection PubMed
description BACKGROUND: Antimicrobial resistance (AR) poses a major global threat, with a reported 1.27 million deaths in 2019. This resulted in years of life lost as well as a large burden on the healthcare system. Transmission of resistant pathogens is not limited to one geographic area and can easily be influenced by international travel and trade of food and other products. Addressing the global threat of AR is recognized as a major action item within the U.S. National Action Plan for Combating Antibiotic Resistant Bacteria. In 2021, the Centers for Disease Control and Prevention (CDC) established the Global Antimicrobial Resistance Laboratory and Response Network (Global AR Lab & Response Network). The network provides financial and technical support to partners, with a focus on detecting and monitoring existing threats, identifying risk factors, preventing and controlling spread, and mitigating the emergence of new threats. METHODS: In just over 2 years, CDC has invested more than $40 million through the Global AR Lab & Response Network on projects with more than 20 organizations in nearly 50 countries. Using a multi-pathogen approach, the network focuses on healthcare-associated, sexually transmitted, fungal, enteric, and invasive bacterial and respiratory pathogens. RESULTS: CDC’s Global AR Lab & Response Network is strengthening capacity to detect and respond to AR threats identified in the CDC 2019 AR Threats Report. Accomplishments include implementing trainings for high quality laboratory methods; monitoring resistance in bacteria and fungi to inform on changes in resistance and improve interventions; training and implementing activities to prevent, detect, and respond to AR in healthcare settings; and enhancing data sharing nationally, regionally, and globally. CONCLUSION: Through this innovative approach with plans for expansion, the Network will continue to use a One-Health methodology to focus on enhancing global capacity to quickly detect AR threats and built upon existing laboratory and response efforts. Findings from these projects will also inform intervention strategies to address current and future AR threats. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677199
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106771992023-11-27 1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats Benoit, Tina Aubert, Rachael Clemente, Jacob Sievert, Dawn Open Forum Infect Dis Abstract BACKGROUND: Antimicrobial resistance (AR) poses a major global threat, with a reported 1.27 million deaths in 2019. This resulted in years of life lost as well as a large burden on the healthcare system. Transmission of resistant pathogens is not limited to one geographic area and can easily be influenced by international travel and trade of food and other products. Addressing the global threat of AR is recognized as a major action item within the U.S. National Action Plan for Combating Antibiotic Resistant Bacteria. In 2021, the Centers for Disease Control and Prevention (CDC) established the Global Antimicrobial Resistance Laboratory and Response Network (Global AR Lab & Response Network). The network provides financial and technical support to partners, with a focus on detecting and monitoring existing threats, identifying risk factors, preventing and controlling spread, and mitigating the emergence of new threats. METHODS: In just over 2 years, CDC has invested more than $40 million through the Global AR Lab & Response Network on projects with more than 20 organizations in nearly 50 countries. Using a multi-pathogen approach, the network focuses on healthcare-associated, sexually transmitted, fungal, enteric, and invasive bacterial and respiratory pathogens. RESULTS: CDC’s Global AR Lab & Response Network is strengthening capacity to detect and respond to AR threats identified in the CDC 2019 AR Threats Report. Accomplishments include implementing trainings for high quality laboratory methods; monitoring resistance in bacteria and fungi to inform on changes in resistance and improve interventions; training and implementing activities to prevent, detect, and respond to AR in healthcare settings; and enhancing data sharing nationally, regionally, and globally. CONCLUSION: Through this innovative approach with plans for expansion, the Network will continue to use a One-Health methodology to focus on enhancing global capacity to quickly detect AR threats and built upon existing laboratory and response efforts. Findings from these projects will also inform intervention strategies to address current and future AR threats. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677199/ http://dx.doi.org/10.1093/ofid/ofad500.1212 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Benoit, Tina
Aubert, Rachael
Clemente, Jacob
Sievert, Dawn
1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
title 1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
title_full 1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
title_fullStr 1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
title_full_unstemmed 1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
title_short 1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
title_sort 1375. strengthening global capacity to detect antimicrobial resistance threats
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677199/
http://dx.doi.org/10.1093/ofid/ofad500.1212
work_keys_str_mv AT benoittina 1375strengtheningglobalcapacitytodetectantimicrobialresistancethreats
AT aubertrachael 1375strengtheningglobalcapacitytodetectantimicrobialresistancethreats
AT clementejacob 1375strengtheningglobalcapacitytodetectantimicrobialresistancethreats
AT sievertdawn 1375strengtheningglobalcapacitytodetectantimicrobialresistancethreats